Alpana Ventures

Tinamu Labs AG, established in 2018 and headquartered in Zurich, Switzerland, specializes in developing software solutions that leverage drone technology for various applications. The company's core offering is a data acquisition platform that enables multi-camera live streaming for sports and filming productions, and provides business management services such as inventory management, inspection tasks, and surveillance. Tinamu Labs' platform processes captured data and generates reports, offering clients precise and consistent data acquisition along with insightful analytics. Originally spun off from the Swiss Federal Institute of Technology in Zurich, the company focuses on robotics and automation, with a particular expertise in autonomous drone flight within warehouses. Tinamu Labs operates in Europe, serving clients from industries including metals, mining, minerals, construction, and biomass, offering automated indoor stockpile volume monitoring services.

Altoida AG is a healthcare company based in Lucerne, Switzerland, established in 2016, focused on developing a platform and application for assessing brain health, particularly in relation to Alzheimer's disease and dementia. The company aims to transform how brain function is measured and neurological diseases are diagnosed, utilizing smartphones and tablets. Its innovative approach leverages over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence. Altoida's flagship product is a Computerized Cognitive Assessment Aid, which is classified as Class II and is exempt from the 510(k) process. This application employs machine learning algorithms to evaluate patients' cognitive and functional abilities, enabling early detection of Alzheimer's and facilitating timely intervention to improve patient outcomes. In recognition of its advanced technology, Altoida received FDA Breakthrough Device Designation in July 2021.

Tinamu Labs AG, established in 2018 and headquartered in Zurich, Switzerland, specializes in developing software solutions that leverage drone technology for various applications. The company's core offering is a data acquisition platform that enables multi-camera live streaming for sports and filming productions, and provides business management services such as inventory management, inspection tasks, and surveillance. Tinamu Labs' platform processes captured data and generates reports, offering clients precise and consistent data acquisition along with insightful analytics. Originally spun off from the Swiss Federal Institute of Technology in Zurich, the company focuses on robotics and automation, with a particular expertise in autonomous drone flight within warehouses. Tinamu Labs operates in Europe, serving clients from industries including metals, mining, minerals, construction, and biomass, offering automated indoor stockpile volume monitoring services.

eMonitor GmbH specializes in property management software tailored for apartment managers, municipalities, and social housing cooperatives. Founded in 2014 and headquartered in Zurich, Switzerland, the company has developed MiMo, a comprehensive B2B platform that digitizes the rental process from initial tenant contact to the signing of rental contracts. This software facilitates the matching of apartments with prospective tenants while optimizing for various factors such as social, environmental, and financial benefits. It streamlines application management, automates credit checks and tenant selection, and supports communication with future tenants. Additionally, eMonitor's platform includes data analysis tools to track the rental process and tenant demographics, allowing property owners to efficiently manage apartment allocations and enhance tenant satisfaction.

DomoHealth is a company that specializes in smart home care services aimed at enhancing the quality of life for seniors and their families. Founded in 2011 by Edouard Goupy and Guillaume DuPasquier, the company emerged from personal experiences that highlighted the need for better care solutions. Between 2012 and 2014, DomoHealth conducted extensive trials and feasibility studies across various European countries, receiving validations from care networks, hospitals, and families. Since 2015, the company has marketed its services through a partner network in Europe, emphasizing a collaborative approach that involves listening to the needs of seniors, families, doctors, and nurses. DomoHealth has demonstrated the effectiveness of its services through partnerships with care networks and has been recognized as an expert in homecare within the framework of the European Commission's AAL program.

LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.

Tinamu Labs AG, established in 2018 and headquartered in Zurich, Switzerland, specializes in developing software solutions that leverage drone technology for various applications. The company's core offering is a data acquisition platform that enables multi-camera live streaming for sports and filming productions, and provides business management services such as inventory management, inspection tasks, and surveillance. Tinamu Labs' platform processes captured data and generates reports, offering clients precise and consistent data acquisition along with insightful analytics. Originally spun off from the Swiss Federal Institute of Technology in Zurich, the company focuses on robotics and automation, with a particular expertise in autonomous drone flight within warehouses. Tinamu Labs operates in Europe, serving clients from industries including metals, mining, minerals, construction, and biomass, offering automated indoor stockpile volume monitoring services.

iGroove AG, founded in 2013 and based in Pfäffikon, Switzerland, specializes in developing music streaming software that offers a comprehensive suite of music distribution and promotion services tailored for artists and independent labels. The platform enables musicians to enhance their reach and revenue through various features, including release strategy consulting, promotion services, advance payments, and playlist pitching. Additionally, iGroove provides marketing tools that allow artists to analyze their performance metrics and manage revenue sharing among collaborators. By facilitating worldwide distribution with a focus on quality, iGroove empowers emerging artists to connect directly with their audience and maximize their earnings while bypassing traditional intermediaries.

Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.

eMonitor GmbH specializes in property management software tailored for apartment managers, municipalities, and social housing cooperatives. Founded in 2014 and headquartered in Zurich, Switzerland, the company has developed MiMo, a comprehensive B2B platform that digitizes the rental process from initial tenant contact to the signing of rental contracts. This software facilitates the matching of apartments with prospective tenants while optimizing for various factors such as social, environmental, and financial benefits. It streamlines application management, automates credit checks and tenant selection, and supports communication with future tenants. Additionally, eMonitor's platform includes data analysis tools to track the rental process and tenant demographics, allowing property owners to efficiently manage apartment allocations and enhance tenant satisfaction.

Altoida AG is a healthcare company based in Lucerne, Switzerland, established in 2016, focused on developing a platform and application for assessing brain health, particularly in relation to Alzheimer's disease and dementia. The company aims to transform how brain function is measured and neurological diseases are diagnosed, utilizing smartphones and tablets. Its innovative approach leverages over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence. Altoida's flagship product is a Computerized Cognitive Assessment Aid, which is classified as Class II and is exempt from the 510(k) process. This application employs machine learning algorithms to evaluate patients' cognitive and functional abilities, enabling early detection of Alzheimer's and facilitating timely intervention to improve patient outcomes. In recognition of its advanced technology, Altoida received FDA Breakthrough Device Designation in July 2021.

LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.

Altoida AG is a healthcare company based in Lucerne, Switzerland, established in 2016, focused on developing a platform and application for assessing brain health, particularly in relation to Alzheimer's disease and dementia. The company aims to transform how brain function is measured and neurological diseases are diagnosed, utilizing smartphones and tablets. Its innovative approach leverages over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence. Altoida's flagship product is a Computerized Cognitive Assessment Aid, which is classified as Class II and is exempt from the 510(k) process. This application employs machine learning algorithms to evaluate patients' cognitive and functional abilities, enabling early detection of Alzheimer's and facilitating timely intervention to improve patient outcomes. In recognition of its advanced technology, Altoida received FDA Breakthrough Device Designation in July 2021.

CodeCheck AG is a Swiss company based in Zurich that has developed a smartphone application designed to help consumers make informed purchasing decisions. Founded in 2007, the CodeCheck app allows users to scan the barcodes of food and cosmetic products in Germany and the USA, providing detailed product descriptions, ingredient lists, and consumer reviews. It offers personalized ratings based on individual user profiles and the latest scientific research, catering to the growing demand for transparency regarding product ingredients and ethical standards. With a user base exceeding 3 million, CodeCheck taps into significant trends in conscious consumption and transparency. Additionally, the company has introduced Oeeda, a market research solution aimed at assisting manufacturers in understanding consumer preferences to drive innovation.

LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.

OneVisage SA is a cybersecurity company based in Lausanne, Switzerland, established in 2013. It specializes in 3D facial authentication technology designed for mobile devices, providing a secure alternative to traditional password-based and biometric solutions. The company offers its proprietary 3DAuth technology through a software development kit (SDK) that enables developers to integrate 3D facial authentication into native mobile applications, as well as a platform-as-a-service (PaaS) option for service providers. OneVisage caters primarily to financial services and identity and access management sectors, allowing businesses to enhance security while ensuring user privacy. Its solutions enable universal strong customer authentication, leveraging depth camera capabilities for a contactless experience across various hardware and platforms.

Altoida AG is a healthcare company based in Lucerne, Switzerland, established in 2016, focused on developing a platform and application for assessing brain health, particularly in relation to Alzheimer's disease and dementia. The company aims to transform how brain function is measured and neurological diseases are diagnosed, utilizing smartphones and tablets. Its innovative approach leverages over 20 years of research in digital biomarkers, augmented reality, and artificial intelligence. Altoida's flagship product is a Computerized Cognitive Assessment Aid, which is classified as Class II and is exempt from the 510(k) process. This application employs machine learning algorithms to evaluate patients' cognitive and functional abilities, enabling early detection of Alzheimer's and facilitating timely intervention to improve patient outcomes. In recognition of its advanced technology, Altoida received FDA Breakthrough Device Designation in July 2021.

Artmyn SA specializes in the digitization of visual artworks, offering a comprehensive platform that allows users to access high-quality digital representations of art through web browsers on various devices, including laptops, smartphones, and tablets. Founded in 2015 and based in Belmont-sur-Lausanne, Switzerland, the company utilizes a portable scanner to capture extensive data about artworks, ensuring accurate and detailed visualizations. Artmyn provides an array of services such as online galleries, interactive guided tours, educational resources, and conservation monitoring tools, catering to museums, galleries, auction houses, and both private and institutional collectors. By enhancing the art viewing experience, Artmyn facilitates greater transparency and engagement for art buyers and enthusiasts alike.

DomoHealth is a company that specializes in smart home care services aimed at enhancing the quality of life for seniors and their families. Founded in 2011 by Edouard Goupy and Guillaume DuPasquier, the company emerged from personal experiences that highlighted the need for better care solutions. Between 2012 and 2014, DomoHealth conducted extensive trials and feasibility studies across various European countries, receiving validations from care networks, hospitals, and families. Since 2015, the company has marketed its services through a partner network in Europe, emphasizing a collaborative approach that involves listening to the needs of seniors, families, doctors, and nurses. DomoHealth has demonstrated the effectiveness of its services through partnerships with care networks and has been recognized as an expert in homecare within the framework of the European Commission's AAL program.

CodeCheck AG is a Swiss company based in Zurich that has developed a smartphone application designed to help consumers make informed purchasing decisions. Founded in 2007, the CodeCheck app allows users to scan the barcodes of food and cosmetic products in Germany and the USA, providing detailed product descriptions, ingredient lists, and consumer reviews. It offers personalized ratings based on individual user profiles and the latest scientific research, catering to the growing demand for transparency regarding product ingredients and ethical standards. With a user base exceeding 3 million, CodeCheck taps into significant trends in conscious consumption and transparency. Additionally, the company has introduced Oeeda, a market research solution aimed at assisting manufacturers in understanding consumer preferences to drive innovation.

LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.

Saphetor SA, founded in 2014 and based in Lausanne, Switzerland, specializes in data-driven solutions aimed at enhancing diagnostics and therapy selection for cancer and challenging medical conditions, including rare diseases and cognitive impairments. The company's flagship platform, VarSome, serves as a comprehensive resource for human genome data, offering extensive variant analyses that assist healthcare professionals in accurately identifying genetic causes of diseases. By facilitating the selection of targeted therapies, stratifying patients for clinical trials, and supporting drug development through sub-population analysis, Saphetor plays a critical role in modern precision medicine. Its technology also aids in the discovery and validation of new drug targets and biomarkers, significantly improving patient outcomes and healthcare practices globally.